BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Drug Development

  G1 Therapeutics Announces Publication in Cancer Discovery Demonstrating That CDK4/6 Inhibition Enhances the Anti-Tumor T Cell Response

  Intermittent dosing of G1’s CDK4/6 inhibitor trilaciclib enhances anti-tumor efficacy of checkpoint inhibitors in preclinical models.

  November 6, 2017

   · 

  3 min read
• Business

  VBL Therapeutics and NanoCarrier Sign Exclusive Agreement for VB-111 in Japan

  Agreement includes $15 million up front, potential milestones payments of more than $100 million, as well as tiered high-teen royalties.

  November 6, 2017

   · 

  6 min read
• Business

  Pluristem Enters Into Agreement With Tel Aviv Sourasky Medical Center to Conduct Phase I/II Trial in Steroid-Refractory Chronic GvHD

  The trial will be an investigator initiated study.

  November 6, 2017

   · 

  5 min read
• Pharm Country

  Alcresta Therapeutics Presented Results at the North American Cystic Fibrosis Conference from the ASSURE Study: An Evaluation of the Long-Term Use of RELiZORB

  Data from the ASSURE study was shared at the North American Cystic Fibrosis Conference that took place November 2-4, 2017 in Indianapolis.

  November 6, 2017

   · 

  4 min read
• Biotech Beach

  UCSC Release: Bioinformatics Leaders Partner to Build Platform for NIH Data Commons

  Bioinformatics experts now view cloud-based computing and data storage as the most effective way to manage and use these rapidly growing biomedical datasets.

  November 6, 2017

   · 

  3 min read
• Drug Development

  Keryx Biopharmaceuticals Announces Presentation of Real World Dialysis Data of Auryxia at ASN’s 2017 Kidney Week

  Auryxia is FDA-approved as a phosphate binder indicated for the control of serum phosphorus levels in adult patients with chronic kidney disease on dialysis.

  November 6, 2017

   · 

  8 min read
• Business

  Almirall’s Q3 Results 2017

  Europe is still a key market in dermatology with sales of 134.6 MM at 9M 2017, boosted by the actinic keratosis franchise and Ciclopoli, the flagship Poli Group product which continues to perform well, and accounted for sales 30.52 MM.

  November 6, 2017

   · 

  7 min read
• Drug Development

  Mitobridge Presents Preclinical Data Demonstrating Beneficial Effects of PPARδ Modulators in Acute Kidney Injury at American Society of Nephrology Annual Meeting

  The data demonstrated that Mitobridge’s proprietary compound MA-0217 corrects the mitochondrial deficits and alleviates the renal dysfunction in a rat ischemia reperfusion AKI model.

  November 6, 2017

   · 

  3 min read
• Biotech Beach

  AMADA MIYACHI AMERICA Highlights Laser and Resistance Welding and Processing Technology at MD&M Minneapolis 2017

  The UB29 is a perfect choice for wire assemblies, sensors, connectors, squibs, catheters, orthodontic appliances, pacemakers and implantable hearing devices.

  November 6, 2017

   · 

  2 min read
• Genetown

  PROMETRIKA to Present Three Sessions at 2017 Medidata NEXT Global in New York

  This event offers keynote speakers, breakout sessions, and interactive learning opportunities for industry leaders around the globe.

  November 6, 2017

   · 

  3 min read